首页 | 本学科首页   官方微博 | 高级检索  
     

三氧化二砷对人肺腺癌A549/R细胞多药耐药相关蛋白表达的影响
引用本文:成静,冯觉平,王亚萍,李敏,孔庆志. 三氧化二砷对人肺腺癌A549/R细胞多药耐药相关蛋白表达的影响[J]. 医药导报, 2007, 26(5): 457-460
作者姓名:成静  冯觉平  王亚萍  李敏  孔庆志
作者单位:1. 武汉大学中南医院肿瘤科,430071;武汉市普爱医院肿瘤科,430030
2. 武汉市普爱医院肿瘤科,430030
基金项目:甘肃省兰州市科技局资助项目
摘    要:目的探讨三氧化二砷(As2O3)对人肺腺癌A549/R细胞耐药性的逆转作用及对多药耐药相关蛋白(MRP)表达的影响。方法以荧光分光光度计测定细胞内药物浓度的改变,采用半定量逆转录聚合酶联反应(RT PCR) 技术检测As2O3处理后A549/R MRP基因表达的变化。结果As2O3的非细胞毒性剂量可增加A549/R细胞内多柔比星(ADM)浓度,降低其IC50。A549/R细胞中MRP呈过表达状态,不同浓度的As2O3处理A549/R后MRP表达水平明显降低。结论As2O3可部分逆转A549/R细胞对ADM的耐药性,其逆转机制与改变MRP基因表达有关。

关 键 词:三氧化二砷  人肺腺癌A549/R细胞  多药耐药  多药耐药相关蛋白
文章编号:1004-0781(2007)05-0457-04
收稿时间:2007-02-01
修稿时间:2007-02-01

Effect of Arsenic Tioxide on MRP Expression in A549/R Cell Line of Human Lung Cancer
CHENG Jing,FENG Jue-ping,WANG Ya-ping,LI Min,KONG Qing-zhi. Effect of Arsenic Tioxide on MRP Expression in A549/R Cell Line of Human Lung Cancer[J]. Herald of Medicine, 2007, 26(5): 457-460
Authors:CHENG Jing  FENG Jue-ping  WANG Ya-ping  LI Min  KONG Qing-zhi
Abstract:Objective To investigate the effect of arsenic trioxide(As2O3) on the reversal role of drug resistance and the expression of MRP in human lung cancer cell line A549/R. Methods The comcentration of intracellular ADM was detected by fluorescence spectrofluorometry.The expression of MRP gene was assessed in As2O3-treated A549/R cells by semiq-uantitative RT-PCR. Results As2O3 in noncytotoxic dose could significantly increase the intracellular accumulation of ADM in A549/R cell line and derease the medium inhibition concentration(IC50).The overexpression of MRP mRNA was observed in A549/R cell line and this was significantly suppressed in As2O3-treated A549/R cells. Conclusion As2O3 can partically reverse the resistance to ADM in A549/R cell line and this effect may be related to the variation of MRP gene expression.
Keywords:Arsenic trioxide  Human lung adenocarcinoma A549/R cell  Multidrug resistance  MRP
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《医药导报》浏览原始摘要信息
点击此处可从《医药导报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号